TYR and early-onset autosomal dominant Alzheimer disease: Given the considerable side effects associated with current Alzheimer’s treatments, targeting tyrosinase inhibition could represent a dual-purpose therapeutic approach, addressing both skin aging and the progression of Alzheimer’s disease.